Showing all 2 results
Capecitabine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Capecitabine USP/Ph.Eur. 150 mg The Precision Titration Anchor: Utilized for accurate dose adjustments based on Body Surface Area (BSA). Capecitabine USP/Ph.Eur. 500 mg The Oncology Macrodose: The primary therapeutic unit for standard cycles in Colorectal and Breast cancer. Excipients Proprietary Matrix High-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust during handling by healthcare professionals. Sorafenib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, child-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the tosylate salt formulation.
Active Ingredient Strength Primary Clinical Function Sorafenib Tosylate INN/Ph.Eur. 200 mg (Equivalent to Sorafenib free base) Global Standard: Base titration unit for the standard 800 mg daily oncology regimen. Excipients Croscarmellose Sodium / Microcrystalline Cellulose / Hypromellose / Magnesium Stearate Superdisintegrant / Diluent / Film-Coating (Engineered for strict gastric dissolution and reliable systemic bioavailability)
